Oakley Capital Investments Limited has announced that Oakley Capital Fund V2 will acquire Flemming Dental, Excent, and Artinorway Group from European Dental Group (EDG) to form one of the leading dental laboratories groups in Europe. The transaction is subject to regulatory approval. Oakley will work closely with the management to establish the Company as an independent business and become a leader in the global dental lab market. The investment will enable the Company to accelerate innovation and the adoption of cutting-edge technology in the dental lab industry. The European dental lab market is valued at approximately €10 billion and offers opportunities for value creation through buy-and-build.